Sherry Aulin has sold XENE and made no open-market buys since Sep 2022

Sherry Aulin is a person, not a company. She was the Chief Financial Officer of Xenon Pharmaceuticals Inc., a role she held from June 2021 until her planned resignation became effective on June 30, 2025; after that date, she was expected to serve in an advisory capacity through August 31, 2025 to support the transition.( Xenon described her departure as being for personal reasons and not related to any disagreement over the company’s financial statements, controls, operations, policies, or practices.(

Aulin has built her career in finance and accounting across Xenon and earlier roles in public-company reporting and audit. Before becoming CFO, she served as Xenon’s Vice President of Finance, Senior Director of Finance, and Director of Finance, and earlier worked as a consultant on public-company financial reporting and compliance as well as in assurance and advisory services at KPMG.( She holds a Bachelor of Commerce (Honours) from The University of British Columbia and a Chartered Professional Accountant designation through CPA Canada; her professional recognition also includes a Business in Vancouver "Forty under 40" award.(

Written by Perplexity from public sources.